PERIPHERALLY INSERTED CENTRAL CATHETER PLACEMENT FOR CANCER PATIENTS . COSTS AVOIDANCE X COST SAVING ANALYSIS

Author(s)

ELIO TANAKA, MD1, Sergio Machado, MD2, GIOVANNA SCARLATTE MARCONDES, RN3.
1MEDICAL AUDIT, TNK MEDICAL AUDIT INSTITUTION, CURITIBA, Brazil, 2RESEARCH, UDELAR / UNIVERSIDADE DE LA REPUBLICA , MONTEVIDEO , URUGUAI, MONTEVIDEO, Uruguay, 3TNK MEDICAL AUDIT INSTITUTION, SÃO PAULO, Brazil.
OBJECTIVES: To analyses the peripherally inserted central catheters placememt as an economic model aplying for the private oncology set patient , studying the cost saving plus avoidance .
METHODS: An economic model to a prospective cohort study was followed by an analysis over a more than 704,000 new cases of cancer expecting for the triennium 2023-2025, previously published at Ispor by the authors. The composite outcome was costs analysis. The economic evaluation was based on reductions in current spending and preventing future expenses. All costs are presented in USD (USA ) ( RATE 1:5 ) .
RESULTS: A total of more than 704,000 cases/ patients were followed in those receiving a PICC line and 85 % of those had no device-related complication . Assuming for comparing the events leading to device removal, the risk of composite endpoint was significantly higher in the CICC group (hazard ratio 0.20; 95% CI 0.11-0.35). The cost of PICC placement was USD 258,19 . In the base case, the ICER for placing a PICC instead of a CICC was USD 669,98 per removal or replacement avoided. On univariate sensitivity analyses, the model proved to be robust within an ICER range of 500.00 to 960.00 USD . In termos of balancing the Equation for Cancer Care, while PICCs boast significant upfront cost savings, their long-term financial impact depends on the duration of cancer treatment and the management of complications.
CONCLUSIONS: In model of Oncologic cases , PICC placement was associated with a lower risk of complications and placement. The costs avoidance versus the cost saving analysis, during inpatient time was dominant. Further study analyses are recommend.

Conference/Value in Health Info

2026-09, ISPOR Asia Pacific 2026, Bangkok, Thailand

Value in Health, Volume 55, Issue S1

Code

RWD6

Topic

Real World Data & Information Systems

Topic Subcategory

Reproducibility & Replicability

Disease

No Additional Disease & Conditions/Specialized Treatment Areas, SDC: Oncology, SDC: Pediatrics, STA: Surgery

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×